 | • レポートコード：D005-11834 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、パーキンソン病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。パーキンソン病治療薬の種類別市場規模（シネメットCR、トラスタル、マドパー、COMT阻害剤、その他）、用途別市場規模（40歳未満、40〜65歳、65歳以上）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Kyowa Hakko Kirin Pharma、Novartis、Akorn、Abbvie、GSK、Desitin Arzneimittel、Teva Pharmaceutical、Boehringer Ingelheim、Astellas Pharma、Apokyn、US WorldMeds、Endo Pharmaceuticals、Orion、Valeant、F.Hoffmann-La Roche、Bausch Health、Stada Arzneimittel、H.Lundbeck ・地域別グローバル市場分析 2015年-2020年 ・パーキンソン病治療薬の北米市場（アメリカ、カナダ、メキシコ） ・パーキンソン病治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・パーキンソン病治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・パーキンソン病治療薬の南米市場（ブラジル、アルゼンチン） ・パーキンソン病治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：シネメットCR、トラスタル、マドパー、COMT阻害剤、その他 ・用途別分析：40歳未満、40〜65歳、65歳以上 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Parkinson’s Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Parkinson’s Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Parkinson’s Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Parkinson’s Disease Drug market has been segmented into
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
By Application, Parkinson’s Disease Drug has been segmented into:
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parkinson’s Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Parkinson’s Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parkinson’s Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Parkinson’s Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Parkinson’s Disease Drug Market Share Analysis
Parkinson’s Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parkinson’s Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parkinson’s Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Parkinson’s Disease Drug are:
Merck
Kyowa Hakko Kirin Pharma
Novartis
Akorn
Abbvie
GSK
Desitin Arzneimittel
Teva Pharmaceutical
Boehringer Ingelheim
Astellas Pharma
Apokyn
US WorldMeds
Endo Pharmaceuticals
Orion
Valeant
F.Hoffmann-La Roche
Bausch Health
Stada Arzneimittel
H.Lundbeck
Among other players domestic and global, Parkinson’s Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parkinson’s Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Parkinson’s Disease Drug, with price, sales, revenue and global market share of Parkinson’s Disease Drug in 2018 and 2019.
Chapter 3, the Parkinson’s Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinson’s Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Parkinson’s Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Parkinson’s Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Parkinson’s Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinson’s Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinson’s Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Overview of Global Parkinson’s Disease Drug Market
1.4.1 Global Parkinson’s Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kyowa Hakko Kirin Pharma
2.2.1 Kyowa Hakko Kirin Pharma Details
2.2.2 Kyowa Hakko Kirin Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kyowa Hakko Kirin Pharma SWOT Analysis
2.2.4 Kyowa Hakko Kirin Pharma Product and Services
2.2.5 Kyowa Hakko Kirin Pharma Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Akorn
2.4.1 Akorn Details
2.4.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Akorn SWOT Analysis
2.4.4 Akorn Product and Services
2.4.5 Akorn Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbvie SWOT Analysis
2.5.4 Abbvie Product and Services
2.5.5 Abbvie Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Desitin Arzneimittel
2.7.1 Desitin Arzneimittel Details
2.7.2 Desitin Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Desitin Arzneimittel SWOT Analysis
2.7.4 Desitin Arzneimittel Product and Services
2.7.5 Desitin Arzneimittel Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceutical SWOT Analysis
2.8.4 Teva Pharmaceutical Product and Services
2.8.5 Teva Pharmaceutical Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astellas Pharma
2.10.1 Astellas Pharma Details
2.10.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Astellas Pharma SWOT Analysis
2.10.4 Astellas Pharma Product and Services
2.10.5 Astellas Pharma Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apokyn
2.11.1 Apokyn Details
2.11.2 Apokyn Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apokyn SWOT Analysis
2.11.4 Apokyn Product and Services
2.11.5 Apokyn Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 US WorldMeds
2.12.1 US WorldMeds Details
2.12.2 US WorldMeds Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 US WorldMeds SWOT Analysis
2.12.4 US WorldMeds Product and Services
2.12.5 US WorldMeds Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Endo Pharmaceuticals
2.13.1 Endo Pharmaceuticals Details
2.13.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Endo Pharmaceuticals SWOT Analysis
2.13.4 Endo Pharmaceuticals Product and Services
2.13.5 Endo Pharmaceuticals Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Orion
2.14.1 Orion Details
2.14.2 Orion Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Orion SWOT Analysis
2.14.4 Orion Product and Services
2.14.5 Orion Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Valeant
2.15.1 Valeant Details
2.15.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Valeant SWOT Analysis
2.15.4 Valeant Product and Services
2.15.5 Valeant Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 F.Hoffmann-La Roche
2.16.1 F.Hoffmann-La Roche Details
2.16.2 F.Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 F.Hoffmann-La Roche SWOT Analysis
2.16.4 F.Hoffmann-La Roche Product and Services
2.16.5 F.Hoffmann-La Roche Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bausch Health
2.17.1 Bausch Health Details
2.17.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bausch Health SWOT Analysis
2.17.4 Bausch Health Product and Services
2.17.5 Bausch Health Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Stada Arzneimittel
2.18.1 Stada Arzneimittel Details
2.18.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Stada Arzneimittel SWOT Analysis
2.18.4 Stada Arzneimittel Product and Services
2.18.5 Stada Arzneimittel Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 H.Lundbeck
2.19.1 H.Lundbeck Details
2.19.2 H.Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 H.Lundbeck SWOT Analysis
2.19.4 H.Lundbeck Product and Services
2.19.5 H.Lundbeck Parkinson’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Parkinson’s Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Parkinson’s Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Parkinson’s Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Parkinson’s Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Parkinson’s Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Parkinson’s Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parkinson’s Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Parkinson’s Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Parkinson’s Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Parkinson’s Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Parkinson’s Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Parkinson’s Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Parkinson’s Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Parkinson’s Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Parkinson’s Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Parkinson’s Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Parkinson’s Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Parkinson’s Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Parkinson’s Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Parkinson’s Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Parkinson’s Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Parkinson’s Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Parkinson’s Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Parkinson’s Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Parkinson’s Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Parkinson’s Disease Drug Price by Type (2015-2020)
11 Global Parkinson’s Disease Drug Market Segment by Application
11.1 Global Parkinson’s Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Parkinson’s Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Parkinson’s Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Parkinson’s Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Parkinson’s Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Parkinson’s Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Parkinson’s Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Parkinson’s Disease Drug Market Forecast (2021-2025)
12.2.4 South America Parkinson’s Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Parkinson’s Disease Drug Market Forecast (2021-2025)
12.3 Parkinson’s Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Parkinson’s Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Parkinson’s Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Parkinson’s Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Parkinson’s Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Parkinson’s Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Parkinson's Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Parkinson's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Parkinson's Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Parkinson's Disease Drug Major Business
Table 9. Merck Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 10. Merck SWOT Analysis
Table 11. Merck Parkinson's Disease Drug Product and Services
Table 12. Merck Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Kyowa Hakko Kirin Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Major Business
Table 15. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 16. Kyowa Hakko Kirin Pharma SWOT Analysis
Table 17. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Product and Services
Table 18. Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Parkinson's Disease Drug Major Business
Table 21. Novartis Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Parkinson's Disease Drug Product and Services
Table 24. Novartis Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Akorn Basic Information, Manufacturing Base and Competitors
Table 26. Akorn Parkinson's Disease Drug Major Business
Table 27. Akorn Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 28. Akorn SWOT Analysis
Table 29. Akorn Parkinson's Disease Drug Product and Services
Table 30. Akorn Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Abbvie Basic Information, Manufacturing Base and Competitors
Table 32. Abbvie Parkinson's Disease Drug Major Business
Table 33. Abbvie Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 34. Abbvie SWOT Analysis
Table 35. Abbvie Parkinson's Disease Drug Product and Services
Table 36. Abbvie Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GSK Basic Information, Manufacturing Base and Competitors
Table 38. GSK Parkinson's Disease Drug Major Business
Table 39. GSK Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 40. GSK SWOT Analysis
Table 41. GSK Parkinson's Disease Drug Product and Services
Table 42. GSK Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Desitin Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 44. Desitin Arzneimittel Parkinson's Disease Drug Major Business
Table 45. Desitin Arzneimittel Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 46. Desitin Arzneimittel SWOT Analysis
Table 47. Desitin Arzneimittel Parkinson's Disease Drug Product and Services
Table 48. Desitin Arzneimittel Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Teva Pharmaceutical Parkinson's Disease Drug Major Business
Table 51. Teva Pharmaceutical Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 52. Teva Pharmaceutical SWOT Analysis
Table 53. Teva Pharmaceutical Parkinson's Disease Drug Product and Services
Table 54. Teva Pharmaceutical Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 56. Boehringer Ingelheim Parkinson's Disease Drug Major Business
Table 57. Boehringer Ingelheim Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 58. Boehringer Ingelheim SWOT Analysis
Table 59. Boehringer Ingelheim Parkinson's Disease Drug Product and Services
Table 60. Boehringer Ingelheim Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Astellas Pharma Parkinson's Disease Drug Major Business
Table 63. Astellas Pharma Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 64. Astellas Pharma SWOT Analysis
Table 65. Astellas Pharma Parkinson's Disease Drug Product and Services
Table 66. Astellas Pharma Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Apokyn Basic Information, Manufacturing Base and Competitors
Table 68. Apokyn Parkinson's Disease Drug Major Business
Table 69. Apokyn Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 70. Apokyn SWOT Analysis
Table 71. Apokyn Parkinson's Disease Drug Product and Services
Table 72. Apokyn Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. US WorldMeds Basic Information, Manufacturing Base and Competitors
Table 74. US WorldMeds Parkinson's Disease Drug Major Business
Table 75. US WorldMeds Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 76. US WorldMeds SWOT Analysis
Table 77. US WorldMeds Parkinson's Disease Drug Product and Services
Table 78. US WorldMeds Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Endo Pharmaceuticals Parkinson's Disease Drug Major Business
Table 81. Endo Pharmaceuticals Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 82. Endo Pharmaceuticals SWOT Analysis
Table 83. Endo Pharmaceuticals Parkinson's Disease Drug Product and Services
Table 84. Endo Pharmaceuticals Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Orion Basic Information, Manufacturing Base and Competitors
Table 86. Orion Parkinson's Disease Drug Major Business
Table 87. Orion Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 88. Orion SWOT Analysis
Table 89. Orion Parkinson's Disease Drug Product and Services
Table 90. Orion Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Valeant Basic Information, Manufacturing Base and Competitors
Table 92. Valeant Parkinson's Disease Drug Major Business
Table 93. Valeant Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 94. Valeant SWOT Analysis
Table 95. Valeant Parkinson's Disease Drug Product and Services
Table 96. Valeant Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. F.Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 98. F.Hoffmann-La Roche Parkinson's Disease Drug Major Business
Table 99. F.Hoffmann-La Roche Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 100. F.Hoffmann-La Roche SWOT Analysis
Table 101. F.Hoffmann-La Roche Parkinson's Disease Drug Product and Services
Table 102. F.Hoffmann-La Roche Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 104. Bausch Health Parkinson's Disease Drug Major Business
Table 105. Bausch Health Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 106. Bausch Health SWOT Analysis
Table 107. Bausch Health Parkinson's Disease Drug Product and Services
Table 108. Bausch Health Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Stada Arzneimittel Parkinson's Disease Drug Type and Application
Table 110. Stada Arzneimittel Parkinson's Disease Drug Major Business
Table 111. Stada Arzneimittel Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 112. Stada Arzneimittel SWOT Analysis
Table 113. Stada Arzneimittel Parkinson's Disease Drug Product and Services
Table 114. Stada Arzneimittel Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 115. H.Lundbeck Basic Information, Manufacturing Base and Competitors
Table 116. H.Lundbeck Parkinson's Disease Drug Major Business
Table 117. H.Lundbeck Parkinson's Disease Drug Total Revenue (USD Million) (2017-2018)
Table 118. H.Lundbeck SWOT Analysis
Table 119. H.Lundbeck Parkinson's Disease Drug Product and Services
Table 120. H.Lundbeck Parkinson's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 121. Global Parkinson's Disease Drug Sales by Manufacturer (2018-2019) (K Doses)
Table 122. Global Parkinson's Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 123. Global Parkinson's Disease Drug Sales by Regions (2015-2020) (K Doses)
Table 124. Global Parkinson's Disease Drug Sales Market Share by Regions (2015-2020)
Table 125. Global Parkinson's Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 126. North America Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 127. North America Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 128. North America Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 129. North America Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 130. Europe Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 131. Europe Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 132. Europe Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 133. Asia-Pacific Parkinson's Disease Drug Sales by Regions (2015-2020) (K Doses)
Table 134. Asia-Pacific Parkinson's Disease Drug Sales Market Share by Regions (2015-2020)
Table 135. Asia-Pacific Parkinson's Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 136. South America Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 137. South America Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 138. South America Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 139. South America Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 140. Middle East & Africa Parkinson's Disease Drug Sales by Countries (2015-2020) (K Doses)
Table 141. Middle East & Africa Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Table 142. Middle East & Africa Parkinson's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 143. Middle East & Africa Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 144. Global Parkinson's Disease Drug Sales by Type (2015-2020) (K Doses)
Table 145. Global Parkinson's Disease Drug Sales Share by Type (2015-2020)
Table 146. Global Parkinson's Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 147. Global Parkinson's Disease Drug Revenue Share by Type (2015-2020)
Table 148. Global Parkinson's Disease Drug Sales by Application (2015-2020) (K Doses)
Table 149. Global Parkinson's Disease Drug Sales Share by Application (2015-2020)
Table 150. Global Parkinson's Disease Drug Sales Forecast by Regions (2021-2025) (K Doses)
Table 151. Global Parkinson's Disease Drug Market Share Forecast by Regions (2021-2025)
Table 152. Global Parkinson's Disease Drug Sales Forecast by Type (2021-2025) (K Doses)
Table 153. Global Parkinson's Disease Drug Market Share Forecast by Type (2021-2025)
Table 154. Global Parkinson's Disease Drug Sales Forecast by Application (2021-2025)
Table 155. Global Parkinson's Disease Drug Market Share Forecast by Application (2021-2025)
Table 156. Direct Channel Pros & Cons
Table 157. Indirect Channel Pros & Cons
Table 158. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Parkinson's Disease Drug Picture
Figure 2. Global Sales Market Share of Parkinson's Disease Drug by Type in 2019
Figure 3. Sinemet-CR Picture
Figure 4. Trastal Picture
Figure 5. Madopar Picture
Figure 6. COMT Inhibitor Picture
Figure 7. Other Picture
Figure 8. Parkinson's Disease Drug Sales Market Share by Application in 2018
Figure 9. Under 40 Years Old Picture
Figure 10. 40-65 Years Old Picture
Figure 11. Above 65 Years Old Picture
Figure 12. Global Parkinson's Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Parkinson's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Parkinson's Disease Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Parkinson's Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Parkinson's Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Parkinson's Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 38. Global Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Parkinson's Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Parkinson's Disease Drug Revenue Market Share by Regions in 2018
Figure 41. North America Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Parkinson's Disease Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Parkinson's Disease Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Parkinson's Disease Drug Sales Market Share by Countries in 2018
Figure 49. North America Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Parkinson's Disease Drug Revenue Market Share by Countries in 2018
Figure 51. United States Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Canada Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 53. Mexico Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. Europe Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Parkinson's Disease Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. UK Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. France Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Russia Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. Italy Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Asia-Pacific Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Parkinson's Disease Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Parkinson's Disease Drug Revenue Market Share by Regions 2019
Figure 65. China Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Japan Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. Korea Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. India Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. Southeast Asia Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. South America Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Parkinson's Disease Drug Sales Market Share by Countries in 2019
Figure 72. South America Parkinson's Disease Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 74. Argentina Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 75. Middle East and Africa Parkinson's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Parkinson's Disease Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Egypt Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. Turkey Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. South Africa Parkinson's Disease Drug Sales and Growth Rate (2015-2020) (K Doses)
Figure 83. Global Parkinson's Disease Drug Sales and Growth Rate (2021-2025) (K Doses)
Figure 84. Global Parkinson's Disease Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Parkinson's Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 86. Europe Sales Parkinson's Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 87. Asia-Pacific Sales Parkinson's Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 88. South America Sales Parkinson's Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 89. Middle East & Africa Sales Parkinson's Disease Drug Market Forecast (2021-2025) (K Doses)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
胃食道逆流症（GERD）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Gastro Esophageal Reflux Disease (GERD) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …- クローン病治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Crohn’s Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Crohn’s Disease Drug mar…
- プロトンポンプ阻害薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Proton Pump Inhibitor Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Proton Pump Inhibi…
- 併用療法薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combination Therapy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Combination Therapy …
- ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…